Medikuntza
Saila
Instituto Nacional de Enfermedades Respiratorias
Ciudad de México, MéxicoInstituto Nacional de Enfermedades Respiratorias-ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2019
-
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study
The Lancet Respiratory Medicine, Vol. 7, Núm. 9, pp. 771-779
2017
-
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: An international case-cohort study
European Respiratory Journal, Vol. 50, Núm. 2
2012
-
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223
-
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2095-2128
-
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196